Pfizer
Marilou T Diaz, RPh, currently serves as Clinical Trial Platform Team Lead and Case Processing Team Lead at Pfizer since October 2016. From January 2007 to October 2016, Marilou held the position of Senior Drug Safety Analyst - Team Lead at Hospira, where responsibilities included allocating team assignments and managing literature events related to generic products throughout their life-cycle. Prior experience includes working as an Information Analyst with Information Analysts Corporation from November 2002 to December 2006, focusing on analyzing patents and journal articles in molecular genetics and gene therapy. Marilou holds a Bachelor of Science in Pharmacy from the University of the Philippines, earned from 1997 to 2001.
This person is not in any teams
This person is not in any offices
Pfizer
614 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.